HomeMidatech Pharma MTX110 could double rare brain tumour survival beyond a yearTumour treatment

Tumour treatment

Most Read

AIM movers: Clean Power Hydrogen revenues delayed and Skillcast rises ahead of results

19/04/2024

FTSE 100 falls as Israel strikes back at Iran

19/04/2024

Currys – the bid whispers are not dying down, while investors agitate for value realisation

19/04/2024

Lloyds earnings preview: are the good times over?

19/04/2024